Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Thymic epithelial tumor × TP protocol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Esophageal Squamous Cell Carcinoma 7 Esophageal Neoplasms 3 Uterine Neoplasms 1 Thyroid Neoplasms 1 Thymoma 1 Thymic epithelial tumor 1 Squamous Cell Carcinoma of Head and Neck 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Mouth Neoplasms 1 Fallopian Tube Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

toripalimab 1 pembrolizumab 1 apatinib 1 TP protocol 1 Radiation 1 Drug Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00818090 2013-04-12

Paclitaxel and Cisplatin for Thymic Neoplasm

Korean Cancer Study Group

Phase 2 Terminated

Thymic epithelial tumor, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡